|
1
|
Lencastre A, Cabete J, João A, Farinha P,
Ferreira G and Lestre S: Blastic plasmacytoid dendritic cell
neoplasm. An Bras Dermatol. 88(Suppl 1): 158–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herling M and Jones D:
CD4+/CD56+ hematodermic tumor: The features
of an evolving entity and its relationship to dendritic cells. Am J
Clin Pathol. 127:687–700. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feuillard J, Jacob MC, Valensi F, Maynadié
M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drénou
B, Duchayne E, et al: Clinical and biologic features of
CD4+CD56+ malignancies. Blood. 99:1556–1563.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H, Thiele J and Vardiman JW: WHO Classification of
Tumours of Haematopoietic and Lymphoid Tissues. (4th).
International Agency for Research on Cancer (IARC) (Lyon).
2008.
|
|
5
|
Shi Y and Wang E: Blastic plasmacytoid
dendritic cell neoplasm: a clinicopathologic review. Arch Pathol
Lab Med. 138:564–569. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petrella T, Bagot M, Willemze R,
Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly
P, Grange F, et al: Blastic NK-cell lymphomas (agranular
CD4+CD56+ hematodermic neoplasms): A review.
Am J Clin Pathol. 123:662–675. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reichard KK, Burks EJ, Foucar MK, Wilson
CS, Viswanatha DS, Hozier JC and Larson RS: CD4+
CD56+ lineage-negative malignancies are rare tumors of
plasmacytoid dendritic cells. Am J Surg Pathol. 29:1274–1283. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Facchetti F, Ungari M, Marocolo D, Lonardi
S and Vermi W: Blastic plasmacytoid dendritic cell neoplasm.
Haematol Meet Rep. 3:1–3. 2009.
|
|
9
|
Pina-Oviedo S, Herrera-Medina H, Coronado
H, Del Valle L and Ortiz-Hidalgo C:
CD4+/CD56+ hematodermic neoplasm:
Presentation of 2 cases and review of the concept of an uncommon
tumor originated in plasmacytoid dendritic cells expressing CD123
(IL-3 receptor alpha). Appl Immunohistochem Mol Morphol.
15:481–486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jegalian AG, Facchetti F and Jaffe ES:
Plasmacytoid dendritic cells: Physiologic roles and pathologic
states. Adv Anat Pathol. 16:392–404. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garnache-Ottou F, Feuillard J, Ferrand C,
Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P,
Maynadié M, et al: Extended diagnostic criteria for plasmacytoid
dendritic cell leukaemia. Br J Haematol. 145:624–636. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Herling M and Jones D:
CD4+/CD56+ hematodermic tumor: The features of an
evolving entity and its relationship to dendritic cells. Am J Clin
Pathol. 127:687–700. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ham MF and Ko YH: Natural killer cell
neoplasm: Biology and pathology. Int J Hematol. 92:681–689. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jegalian AG, Buxbaum NP, Facchetti F,
Raffeld M, Pittaluga S, Wayne AS and Jaffe ESL: Blastic
plasmacytoid dendritic cell neoplasm in children: Diagnostic
features and clinical implications. Haematologica. 95:1873–1879.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dietrich S, Andrulis M, Hegenbart U,
Schmitt T, Bellos F, Martens UM, Meissner J, Krämer A, Ho AD and
Dreger P: Blastic plasmacytoid dendritic cell neoplasia (BPDC) in
elderly patients: Results of a treatment algorithm employing
allogeneic stem cell transplantation with moderately reduced
conditioning intensity. Biol Blood Marrow Transplant. 17:1250–1254.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rauh MJ, Rahman F, Good D, Silverman J,
Brennan MK, Dimov N, Liesveld J, Ryan DH, Burack WR and Bennett JM:
Blastic plasmacytoid dendritic cell neoplasm with leukemic
presentation, lacking cutaneous involvement: Case series and
literature review. Leuk Res. 36:81–86. 2012. View Article : Google Scholar : PubMed/NCBI
|
